ViaDerma Completes First Shipment of 500,000 Units to Nigeria LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...

$7+ Billion Aesthetic Lasers Market Size to Grow at a Rapid Pace by 2028 at 16+% CAGR | The Insight Partners New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Aesthetic Lasers Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...

ScarX announces approval for trial of first clinically-promising scar reduction cream TORONTO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a...

ScarX Therapeutics closes $2 million Series A financing TORONTO, Feb. 16, 2016 (GLOBE NEWSWIRE) -- ScarX Therapeutics, a Canadian biotechnology company commercializing innovative treatments for dermal scarring (fibrosis), has closed a $2 million Series A...